A previous results card (RC-TEC14) was used to develop the present assessment element.
No additional information is required for patients or individuals outside the target group concerning indications/contraindications, the procedure, and role of test in the diagnostic/therapeutic pathway. In the case of the test results, confidentiality is a major concern; no other people apart from the patient need to be informed about them.
Pseudo169 P et al. Result Card TEC15 In: Pseudo169 P et al. Description and technical characteristics of technology In: Jefferson T, Vicari N, Raatz H [eds.]. Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX ) [Core HTA], Agenzia nationale per i servizi sanitari regionali (age.na.s), Italy ; 2013. [cited 7 February 2023]. Available from: http://corehta.info/ViewCover.aspx?id=113